APA (7th ed.) Citation

Whittle, J., Rosenthal, M., Spiteri, M., Cain, S., Topp, M., Shaya, S., . . . Drummond, K. (2024). 443O A perioperative study of safusidenib in patients with IDH1 mutated glioma. Annals of Oncology, 35, S407. https://doi.org/10.1016/j.annonc.2024.08.513

Chicago Style (17th ed.) Citation

Whittle, J.R, et al. "443O A Perioperative Study of Safusidenib in Patients with IDH1 Mutated Glioma." Annals of Oncology 35 (2024): S407. https://doi.org/10.1016/j.annonc.2024.08.513.

MLA (9th ed.) Citation

Whittle, J.R, et al. "443O A Perioperative Study of Safusidenib in Patients with IDH1 Mutated Glioma." Annals of Oncology, vol. 35, 2024, p. S407, https://doi.org/10.1016/j.annonc.2024.08.513.